GI Biome is a clinical stage microbiome therapeutics company with a highly differentiated pipeline that includes Live Bacterial Therapeutics for oncology, metabolic diseases, allergic diseases, and gastrointestinal diseases. Our bench-to-bedside strategy enables accelerated clinical development of the LBPs, along with our cutting-edge preclinical research facility and bioinformatic expertise.
Company Details
- Employees
- 5
- Founded
- -
- Address
- B-1567, Seongnam Skv1 Tower, 288-14, Galmachiro, Jungwon-Gu, Seongnam,13201,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Seongnam
Gi Biome Questions
Gi Biome's website is https://gi-biome.com/en/index.php
Gi Biome's LinkedIn profile is https://kr.linkedin.com/company/gi-biome
Gi Biome has
5 employees.
View email and phone details for 5
employees at Gi Biome.
Gi Biome's industry is
Biotechnology Research
Gi Biome's top competitors are
Genome & Company,
Yuyu Pharma,
Kimco(Korea Innovative Medicines Consortium),
Jeio Tech,
Genemedi Biotech,
Gi Cell (지아이셀),
Immunobiome Inc.,
Gi Innovation,
Neogentc,
Imbdx.
Gi Biome's categories are Biotechnology Research
Gi Biome's founding year is 2018
